Patrick O'Gara is a Cardiology physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Cardiovascular Division
Boston, MA 02115
Telephone
857-307-1990Provider last certified this registry record 5 Jun 2026.
Clinical trials
6 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.5%Statin21.5%Atorvastatin Calcium68%Rosuvastatin Calcium27%Pravastatin Sodium4%Simvastatin2%Part D<11 patientsBeta blocker17.4%Metoprolol Succinate72%Carvedilol10%Bisoprolol Fumarate5%Nadolol4%Metoprolol Tartrate4%Atenolol4%Labetalol Hcl2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
13.7%Factor Xa inhibitor11.9%Eliquis78%Xarelto23%Part D≥107 patientsP2Y12 inhibitor1.3%Clopidogrel100%Part D≥18 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.8%SGLT2 inhibitor2%Jardiance100%Part D≥23 patientsPotassium supplement1%Klor-Con M2051%Potassium Chloride49%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”